Noneligible Donors as a Strategy to Decrease the Organ Shortage

K. P. Croome, D. D. Lee, A. P. Keaveny, C. B. Taner

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Organ procurement organization (OPO) performance is generally evaluated by the number of organ procurement procedures divided by the number of eligible deaths (donation after brain death [DBD] donors aged <70 years), whereas the number of noneligible deaths (including donation after cardiac death donors and DBD donors aged >70 years) is not tracked. The present study aimed to investigate the variability in the proportion of noneligible liver donors by the 58 donor service areas (DSAs). Patients undergoing liver transplant (LT) between 2011 and 2015 were obtained from the United Network for Organ Sharing Standard Transplant Analysis and Research file. LTs from noneligible and eligible donors were compared. The proportion of noneligible liver donors by DSA varied significantly, ranging from 0% to 19.6% of total liver grafts used. In transplant programs, the proportion of noneligible liver donors used ranged from 0% to 35.3%. On linear regression there was no correlation between match Model for End-Stage Liver Disease score for programs in a given DSA and proportion of noneligible donors used from the corresponding DSA (p = 0.14). Noneligible donors remain an underutilized resource in many OPOs. Policy changes to begin tracking noneligible donors and learning from OPOs that have high noneligible donor usage are potential strategies to increase awareness and pursuit of these organs.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StateAccepted/In press - 2017

Fingerprint

Tissue Donors
Liver
Transplants
Tissue and Organ Procurement
End Stage Liver Disease
Brain Death
Linear Models
Learning
Organizations
Research

Keywords

  • Clinical research/practice
  • Donors and donation: donation after circulatory death (DCD)
  • Donors and donation: extended criteria
  • Health services and outcomes research
  • Liver transplantation/hepatology
  • Organ procurement and allocation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Noneligible Donors as a Strategy to Decrease the Organ Shortage. / Croome, K. P.; Lee, D. D.; Keaveny, A. P.; Taner, C. B.

In: American Journal of Transplantation, 2017.

Research output: Contribution to journalArticle

Croome, K. P. ; Lee, D. D. ; Keaveny, A. P. ; Taner, C. B. / Noneligible Donors as a Strategy to Decrease the Organ Shortage. In: American Journal of Transplantation. 2017.
@article{520214cea4be4711b3e4bc684fff0168,
title = "Noneligible Donors as a Strategy to Decrease the Organ Shortage",
abstract = "Organ procurement organization (OPO) performance is generally evaluated by the number of organ procurement procedures divided by the number of eligible deaths (donation after brain death [DBD] donors aged <70 years), whereas the number of noneligible deaths (including donation after cardiac death donors and DBD donors aged >70 years) is not tracked. The present study aimed to investigate the variability in the proportion of noneligible liver donors by the 58 donor service areas (DSAs). Patients undergoing liver transplant (LT) between 2011 and 2015 were obtained from the United Network for Organ Sharing Standard Transplant Analysis and Research file. LTs from noneligible and eligible donors were compared. The proportion of noneligible liver donors by DSA varied significantly, ranging from 0{\%} to 19.6{\%} of total liver grafts used. In transplant programs, the proportion of noneligible liver donors used ranged from 0{\%} to 35.3{\%}. On linear regression there was no correlation between match Model for End-Stage Liver Disease score for programs in a given DSA and proportion of noneligible donors used from the corresponding DSA (p = 0.14). Noneligible donors remain an underutilized resource in many OPOs. Policy changes to begin tracking noneligible donors and learning from OPOs that have high noneligible donor usage are potential strategies to increase awareness and pursuit of these organs.",
keywords = "Clinical research/practice, Donors and donation: donation after circulatory death (DCD), Donors and donation: extended criteria, Health services and outcomes research, Liver transplantation/hepatology, Organ procurement and allocation",
author = "Croome, {K. P.} and Lee, {D. D.} and Keaveny, {A. P.} and Taner, {C. B.}",
year = "2017",
doi = "10.1111/ajt.14163",
language = "English (US)",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Noneligible Donors as a Strategy to Decrease the Organ Shortage

AU - Croome, K. P.

AU - Lee, D. D.

AU - Keaveny, A. P.

AU - Taner, C. B.

PY - 2017

Y1 - 2017

N2 - Organ procurement organization (OPO) performance is generally evaluated by the number of organ procurement procedures divided by the number of eligible deaths (donation after brain death [DBD] donors aged <70 years), whereas the number of noneligible deaths (including donation after cardiac death donors and DBD donors aged >70 years) is not tracked. The present study aimed to investigate the variability in the proportion of noneligible liver donors by the 58 donor service areas (DSAs). Patients undergoing liver transplant (LT) between 2011 and 2015 were obtained from the United Network for Organ Sharing Standard Transplant Analysis and Research file. LTs from noneligible and eligible donors were compared. The proportion of noneligible liver donors by DSA varied significantly, ranging from 0% to 19.6% of total liver grafts used. In transplant programs, the proportion of noneligible liver donors used ranged from 0% to 35.3%. On linear regression there was no correlation between match Model for End-Stage Liver Disease score for programs in a given DSA and proportion of noneligible donors used from the corresponding DSA (p = 0.14). Noneligible donors remain an underutilized resource in many OPOs. Policy changes to begin tracking noneligible donors and learning from OPOs that have high noneligible donor usage are potential strategies to increase awareness and pursuit of these organs.

AB - Organ procurement organization (OPO) performance is generally evaluated by the number of organ procurement procedures divided by the number of eligible deaths (donation after brain death [DBD] donors aged <70 years), whereas the number of noneligible deaths (including donation after cardiac death donors and DBD donors aged >70 years) is not tracked. The present study aimed to investigate the variability in the proportion of noneligible liver donors by the 58 donor service areas (DSAs). Patients undergoing liver transplant (LT) between 2011 and 2015 were obtained from the United Network for Organ Sharing Standard Transplant Analysis and Research file. LTs from noneligible and eligible donors were compared. The proportion of noneligible liver donors by DSA varied significantly, ranging from 0% to 19.6% of total liver grafts used. In transplant programs, the proportion of noneligible liver donors used ranged from 0% to 35.3%. On linear regression there was no correlation between match Model for End-Stage Liver Disease score for programs in a given DSA and proportion of noneligible donors used from the corresponding DSA (p = 0.14). Noneligible donors remain an underutilized resource in many OPOs. Policy changes to begin tracking noneligible donors and learning from OPOs that have high noneligible donor usage are potential strategies to increase awareness and pursuit of these organs.

KW - Clinical research/practice

KW - Donors and donation: donation after circulatory death (DCD)

KW - Donors and donation: extended criteria

KW - Health services and outcomes research

KW - Liver transplantation/hepatology

KW - Organ procurement and allocation

UR - http://www.scopus.com/inward/record.url?scp=85011029475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011029475&partnerID=8YFLogxK

U2 - 10.1111/ajt.14163

DO - 10.1111/ajt.14163

M3 - Article

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -